Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer

(2011) M. C. Garassino et al.   ANNALS OF ONCOLOGY

The BATTLE Trial: Personalizing Therapy for Lung Cancer

(2011) Edward S. Kim et al.   Cancer Discovery

Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling

(2010) J. P. Sullivan et al.   CANCER RESEARCH

Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival

(2010) Matthias Drosten et al.   EMBO JOURNAL

Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms

(2009) E.A. Dunlop et al.   CELLULAR SIGNALLING

Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: Etiopathogenic similarities, differences and paradoxes

(2009) Miquel Porta et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Are RAS mutations predictive markers of resistance to standard chemotherapy?

(2009) Yohann Loriot et al.   Nature Reviews Clinical Oncology

SnapShot: Ras Signaling

(2008) Megan Cully et al.   CELL

KRAS mutations predict response to EGFR inhibitors

(2008) Mitch Raponi et al.   CURRENT OPINION IN PHARMACOLOGY

Mapping the Nucleotide and Isoform-Dependent Structural and Dynamical Features of Ras Proteins

(2008) Alemayehu A. Gorfe et al.   STRUCTURE

Effects of mutant human Ki-rasG12C gene dosage on murine lung tumorigenesis and signaling to its downstream effectors

(2008) Stephanie T. Dance-Barnes et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY